Back to search

Peptide record

TPDB26966

Antibacterial Toxicity modified_plain modified
6 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB26966
Antibacterial Toxicity
Anti-infective peptides Toxicity and safety peptides
Peptipedia
modified_plain
Yes
A 6-aa modified multi-activity (Antibacterial and Toxicity) peptide sequence curated from Peptipedia, with an available 3D structural model.
Modified, details unspecified
Sequence
XRXRXR
Physicochemical Analysis
C18H38N12O4
ANDCEQGHILKMFPSTWYV
R
486.58
12.70
3
0
0
+3
2.43
-2.250
0.00
Mammalian: Yeast: E.coli:
0
0.00
0
Residue Composition
number
0
A
3
R
0
N
0
D
0
C
0
E
0
Q
0
G
0
H
0
I
0
L
0
K
0
M
0
F
0
P
0
S
0
T
0
W
0
Y
0
V
Amino Acid Distribution
A: 0 R: 3 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 0 H: 0 I: 0 L: 0 K: 0 M: 0 F: 0 P: 0 S: 0 T: 0 W: 0 Y: 0 V: 0
Chemical Descriptors
6
C18H38N12O4
486.58
12.70
+3
2.43
-2.250
Evidence Records 2 records
Evidence 1 Activity

Activity

0% Hemolysis
Toxicity
91.52 µg/mL
Hemolytic Cytotoxic
0% Hemolysis | 91.52 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
The Design of Alapropoginine, a Novel Conjugated Ultrashort Antimicrobial Peptide with Potent Synergistic Antimicrobial Activity in Combination with Conventional Antibiotics | Antibiotics (Basel) | 2021
Evidence 2 Activity

Activity

1% Hemolysis
Toxicity
114.4 µg/mL
Hemolytic Cytotoxic
1% Hemolysis | 114.4 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
The Design of Alapropoginine, a Novel Conjugated Ultrashort Antimicrobial Peptide with Potent Synergistic Antimicrobial Activity in Combination with Conventional Antibiotics | Antibiotics (Basel) | 2021